RXRG
Retinoic acid receptor RXR-gamma
Also known as: NR2B3, RXR-gamma, RXRG_HUMAN, RXRgamma
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48443
- Gene
- RXRG
- Ensembl
- ENSG00000143171
- Chromosome
- 1
- Canonical length
- 463 aa
- Protein class
- Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the antiproliferative effects of retinoic acid (RA). This receptor forms dimers with the retinoic acid, thyroid hormone, and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. This gene is expressed at significantly lower levels in non-small cell lung cancer cells. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
463 residues, UniProt reviewed canonical sequence.
>P48443|RXRG
1 MYGNYSHFMK FPAGYGGSPG HTGSTSMSPS AALSTGKPMD SHPSYTDTPV SAPRTLSAVG
61 TPLNALGSPY RVITSAMGPP SGALAAPPGI NLVAPPSSQL NVVNSVSSSE DIKPLPGLPG
121 IGNMNYPSTS PGSLVKHICA ICGDRSSGKH YGVYSCEGCK GFFKRTIRKD LIYTCRDNKD
181 CLIDKRQRNR CQYCRYQKCL VMGMKREAVQ EERQRSRERA ESEAECATSG HEDMPVERIL
241 EAELAVEPKT ESYGDMNMEN STNDPVTNIC HAADKQLFTL VEWAKRIPHF SDLTLEDQVI
301 LLRAGWNELL IASFSHRSVS VQDGILLATG LHVHRSSAHS AGVGSIFDRV LTELVSKMKD
361 MQMDKSELGC LRAIVLFNPD AKGLSNPSEV ETLREKVYAT LEAYTKQKYP EQPGRFAKLL
421 LRLPALRSIG LKCLEHLFFF KLIGDTPIDT FLMEMLETPL QITLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RXRG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 47 nTPM
- pituitary gland: 30 nTPM
- retina: 23 nTPM
- basal ganglia: 20 nTPM
- spinal cord: 16 nTPM
- hypothalamus: 14 nTPM
Single-cell type
- somatotrophs: 143 nCPM
- cone photoreceptor cells: 135 nCPM
- myosatellite cells: 60 nCPM
- retinal ganglion cells: 54 nCPM
- thyrotrophs: 41 nCPM
- schwann cells: 38 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 50 nTPM
- medulla oblongata: 38 nTPM
- pons: 30 nTPM
- cerebral cortex: 17 nTPM
- basal ganglia: 17 nTPM
- white matter: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RXRG.
Disease | ImmuneIEDB
Conditions an epitope on RXRG was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
- sleep disorder B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.42
- gnomAD missense Z
- 1.59
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- nervous system development
- positive regulation of transcription by RNA polymerase II
- retinoic acid receptor signaling pathway
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- molecular condensate scaffold activity
- nuclear receptor activity
- nuclear steroid receptor activity
- retinoic acid-responsive element binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Retinoid X receptor/HNF4
- Nuclear hormone receptor, ligand-binding domain
- Zinc finger, nuclear hormone receptor-type
- Nuclear hormone receptor
- Zinc finger, NHR/GATA-type
- Nuclear/hormone receptor activator site AF-1
- Nuclear hormone receptor-like domain superfamily
- Nuclear hormone receptor family NR2 subfamily
- Ligand-binding domain of nuclear hormone receptor
- Double treble clef zinc finger, C4 type
- Nuclear/hormone receptor activator site AF-1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RXRG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RXRG as an antibody target. Whether an autoantibody or antibody against RXRG could matter depends on whether native RXRG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RXRG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RXRG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...